Literature DB >> 15964923

Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension.

Chen-Fuh Lam1, Timothy E Peterson, Anthony J Croatt, Karl A Nath, Zvonimir S Katusic.   

Abstract

Patients with left-to-right shunt congenital heart disease may develop pulmonary hypertension. Perioperative mortality of these patients is high due to abnormal vasoreactivity of the pulmonary artery (PA). We studied the changes in the PA induced by high pulmonary blood flow in rats with aortocaval fistula. Eight weeks after surgery, morphological changes of the PA were studied and vasomotor function was assessed by isometric force recording. Expression of endothelial nitric oxide (NO) synthase (eNOS), VEGF, and cyclooxygenase-2 (COX-2) proteins and levels of cGMP in the PA were analyzed. Rats with high pulmonary blood flow developed pulmonary hypertension, medial thickening, and increasing of internal elastic lamina and basement membrane in the PA. When compared with sham-operated animals, rats with fistula had significantly increased contractions in the PA, whereas relaxations to acetylcholine and NO donor were reduced. Concentrations of cGMP were reduced in the PA of rats with pulmonary hypertension (18.4 +/- 3.3 vs. 9.4 +/- 1.7 pmol/mg protein; P = 0.04). The altered vasomotor function was normalized by treatment with indomethacin. The PA of rats with fistula expressed higher levels of eNOS, phosphorylated eNOS, and COX-2. Sustained high PA blood flow in rats causes pulmonary hypertension that is morphologically and functionally identical with patients with flow-induced pulmonary hypertension. Abnormal vasomotor function of the PA in these animals appears to be mediated by reduced availability and the biological effect of endogenous NO and the high production of vasoconstrictor prostanoids. Increased eNOS and phosphorylated eNOS are most likely the adaptive changes in response to an increase in PA pressure secondary to high blood flow.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964923     DOI: 10.1152/ajpheart.00375.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

1.  Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.

Authors:  Jing Tian; Sohrab Fratz; Yali Hou; Qing Lu; Agnes Görlach; John Hess; Christian Schreiber; Sanjeev A Datar; Peter Oishi; John Nechtman; Robert Podolsky; Jin-Xiong She; Jeffrey R Fineman; Stephen M Black
Journal:  Physiol Genomics       Date:  2010-10-26       Impact factor: 3.107

2.  The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.

Authors:  Pascal Guerard; Zo Rakotoniaina; Françoise Goirand; Luc Rochette; Monique Dumas; Frederic Lirussi; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

3.  MicroRNA-338-5p modulates pulmonary hypertension-like injuries caused by SO2, NO2 and PM2.5 co-exposure through targeting the HIF-1α/Fhl-1 pathway.

Authors:  Xiaotong Ji; Yingying Zhang; Tingting Ku; Yang Yun; Guangke Li; Nan Sang
Journal:  Toxicol Res (Camb)       Date:  2016-09-09       Impact factor: 3.524

4.  The effect of distal pulmonary obstruction or elevated atrial pressures on pulmonary flow and pulmonary vascular disease: a mathematical flow circuit analogy model-based analysis.

Authors:  Balram Babu Rajanbabu; Raviraju Chigullapally
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-04-26

5.  Angiogenic biomarkers in children with congenital heart disease: possible implications.

Authors:  Nagla T El-Melegy; Nagwa A Mohamed
Journal:  Ital J Pediatr       Date:  2010-04-20       Impact factor: 2.638

6.  S-nitrosothiols signal hypoxia-mimetic vascular pathology.

Authors:  Lisa A Palmer; Allan Doctor; Preeti Chhabra; Mary Lynn Sheram; Victor E Laubach; Molly Z Karlinsey; Michael S Forbes; Timothy Macdonald; Benjamin Gaston
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

8.  Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat.

Authors:  Noel M Caplice; Shaohua Wang; Michal Tracz; Anthony J Croatt; Joseph P Grande; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2007-03-06

9.  Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.

Authors:  David M Smadja; Laetitia Mauge; Pascale Gaussem; Clément d'Audigier; Dominique Israel-Biet; David S Celermajer; Damien Bonnet; Marilyne Lévy
Journal:  Angiogenesis       Date:  2010-11-04       Impact factor: 9.596

10.  Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.

Authors:  Walid Habre; Gergely Albu; Tibor Z Janosi; Fabienne Fontao; Britta S von Ungern-Sternberg; Maurice Beghetti; Ferenc Petak
Journal:  Respir Res       Date:  2011-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.